PMC:7696151 / 78951-79142
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2382 | 86-91 | Gene | denotes | Bcl-2 | Gene:12043 |
| 2392 | 186-190 | Species | denotes | mice | Tax:10090 |
| 2407 | 128-131 | Chemical | denotes | HCQ | MESH:D006886 |
| 2436 | 164-177 | Disease | denotes | neuroblastoma | MESH:D009447 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T176 | 164-177 | Phenotype | denotes | neuroblastoma | http://purl.obolibrary.org/obo/HP_0003006 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T506 | 0-191 | Sentence | denotes | In the same way, Fenollar, et al. [153] demonstrated the efficacy of Obatoclax, a pan-Bcl-2 inhibitor, used in association with HCQ (3–60 mg/kg) or conventional in neuroblastoma-bearing mice. |